271 related articles for article (PubMed ID: 22933160)
1. Effect of iron overload on endocrinopathies in patients with beta-thalassaemia major and intermedia.
Kurtoglu AU; Kurtoglu E; Temizkan AK
Endokrynol Pol; 2012; 63(4):260-3. PubMed ID: 22933160
[TBL] [Abstract][Full Text] [Related]
2. Mild subclinical hypothyroidism in thalassaemia major: prevalence, multigated radionuclide test, clinical and laboratory long-term follow-up study.
De Sanctis V; De Sanctis E; Ricchieri P; Gubellini E; Gilli G; Gamberini MR
Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():174-80. PubMed ID: 19337174
[TBL] [Abstract][Full Text] [Related]
3. Serum ferritin levels and endocrinopathy in medically treated patients with β thalassemia major.
Belhoul KM; Bakir ML; Saned MS; Kadhim AM; Musallam KM; Taher AT
Ann Hematol; 2012 Jul; 91(7):1107-14. PubMed ID: 22281991
[TBL] [Abstract][Full Text] [Related]
4. Endocrine complications in patients with Thalassaemia Major.
Toumba M; Sergis A; Kanaris C; Skordis N
Pediatr Endocrinol Rev; 2007 Dec; 5(2):642-8. PubMed ID: 18084158
[TBL] [Abstract][Full Text] [Related]
5. Thyroid function in thalassaemia major.
Senanayake MP; Suraweera SA; Hubert HD
Ceylon Med J; 1999 Dec; 44(4):166-8. PubMed ID: 10895267
[TBL] [Abstract][Full Text] [Related]
6. Normalisation of total body iron load with very intensive combined chelation reverses cardiac and endocrine complications of thalassaemia major.
Farmaki K; Tzoumari I; Pappa C; Chouliaras G; Berdoukas V
Br J Haematol; 2010 Feb; 148(3):466-75. PubMed ID: 19912219
[TBL] [Abstract][Full Text] [Related]
7. Endocrinopathies, metabolic disorders, and iron overload in major and intermedia thalassemia: serum ferritin as diagnostic and predictive marker associated with liver and cardiac T2* MRI assessment.
Chirico V; Rigoli L; Lacquaniti A; Salpietro V; Piraino B; Amorini M; Salpietro C; Arrigo T
Eur J Haematol; 2015 May; 94(5):404-12. PubMed ID: 25200112
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of iron overload complications among patients with b-thalassemia major treated at Dubai Thalassemia Centre.
Belhoul KM; Bakir ML; Kadhim AM; Dewedar HE; Eldin MS; Alkhaja FA
Ann Saudi Med; 2013; 33(1):18-21. PubMed ID: 23458935
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of endocrine complications in beta-thalassaemia major in the Islamic Republic of Iran.
Karamifar H; Shahriari M; Sadjadian N
East Mediterr Health J; 2003; 9(1-2):55-60. PubMed ID: 15562733
[TBL] [Abstract][Full Text] [Related]
10. Assessment of thyroid function in two hundred patients with beta-thalassemia major.
Zervas A; Katopodi A; Protonotariou A; Livadas S; Karagiorga M; Politis C; Tolis G
Thyroid; 2002 Feb; 12(2):151-4. PubMed ID: 11916284
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of endocrine disorders and their associated factors in transfusion-dependent thalassemia patients: a historical cohort study in Southern Iran.
Bordbar M; Bozorgi H; Saki F; Haghpanah S; Karimi M; Bazrafshan A; Zekavat OR
J Endocrinol Invest; 2019 Dec; 42(12):1467-1476. PubMed ID: 31228105
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of endocrine complications and short stature in patients with thalassaemia major: a multicenter study by the Thalassaemia International Federation (TIF).
De Sanctis V; Eleftheriou A; Malaventura C;
Pediatr Endocrinol Rev; 2004 Dec; 2 Suppl 2():249-55. PubMed ID: 16462705
[TBL] [Abstract][Full Text] [Related]
13. A cross-sectional study of metabolic and endocrine complications in beta-thalassemia major.
Najafipour F; Aliasgarzadeh A; Aghamohamadzadeh N; Bahrami A; Mobasri M; Niafar M; Khoshbaten M
Ann Saudi Med; 2008; 28(5):361-6. PubMed ID: 18779644
[TBL] [Abstract][Full Text] [Related]
14. Increased sensitivity to the inhibitory effect of excess iodide on thyroid function in patients with beta-thalassemia major and iron overload and the subsequent development of hypothyroidism.
Alexandrides T; Georgopoulos N; Yarmenitis S; Vagenakis AG
Eur J Endocrinol; 2000 Sep; 143(3):319-25. PubMed ID: 11022172
[TBL] [Abstract][Full Text] [Related]
15. Cardiomyopathy and pericardial effusion in a 7 year-old boy with beta-thalassaemia major, severe primary hypothyroidism and hypoparathyroidism due to iron overload.
De Sanctis V; Govoni MR; Sprocati M; Marsella M; Conti E
Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():181-4. PubMed ID: 19337175
[TBL] [Abstract][Full Text] [Related]
16. Deferasirox administration for the treatment of non-transfusional iron overload in patients with thalassaemia intermedia.
Ladis V; Berdousi H; Gotsis E; Kattamis A
Br J Haematol; 2010 Dec; 151(5):504-8. PubMed ID: 20950401
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic iron and glucose dysregulation in thalassemia major.
Noetzli LJ; Mittelman SD; Watanabe RM; Coates TD; Wood JC
Am J Hematol; 2012 Feb; 87(2):155-60. PubMed ID: 22120775
[TBL] [Abstract][Full Text] [Related]
18. An ICET- A survey on Hypoparathyroidism in Patients with Thalassaemia Major and Intermedia: A preliminary report.
De Sanctis V; Soliman AT; Canatan D; Elsedfy H; Karimi M; Daar S; Rimawi H; Christou S; Skordis N; Tzoulis P; Sobti P; Kakkar S; Kilinc Y; Khater D; Alyaarubi SA; Kaleva V; Lum SH; Yassin MA; Saki F; Obiedat M; Anastasi S; Galati MC; Raiola G; Campisi S; Soliman N; Elshinawy M; Jaouni SA; Di Maio S; Wali Y; Elhakim IZ; Kattamis C
Acta Biomed; 2018 Jan; 88(4):435-444. PubMed ID: 29350657
[TBL] [Abstract][Full Text] [Related]
19. Endocrine gland abnormalities in thalassemia major: a brief review.
Mohammadian S; Bazrafshan HR; Sadeghi-Nejad A
J Pediatr Endocrinol Metab; 2003 Sep; 16(7):957-64. PubMed ID: 14513870
[TBL] [Abstract][Full Text] [Related]
20. Hypogonadism, diabetes mellitus, hypothyroidism, hypoparathyroidism: incidence and prevalence related to iron overload and chelation therapy in patients with thalassaemia major followed from 1980 to 2007 in the Ferrara Centre.
Gamberini MR; De Sanctis V; Gilli G
Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():158-69. PubMed ID: 19337172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
